Yoonjin Kwak

2.3k citations
79 papers · 1.4k indexed · h-index 21
Topics
Gastric Cancer Management and Outcomes (23 papers)Cancer Immunotherapy and Biomarkers (17 papers)Colorectal Cancer Treatments and Studies (15 papers)

In The Last Decade

Yoonjin Kwak

72 papers receiving 1.4k citations

Peers

Yoonjin Kwak
Comparison fields: 5 of 75
  • Oncology 949
  • Pulmonary and Respiratory Medicine 437
  • Molecular Biology 339
  • Pathology and Forensic Medicine 282
  • Surgery 248
Replace Laura Casorzo with:
Laura Casorzo Italy
Naoki Kanomata Japan
So Young Kang South Korea
Sara Cresta Italy
Edward Arrowsmith United States
Alice Parisi Italy
Ettore Macrì Italy
Naoki Takahashi Japan
Hongfen Lu China
Helene Geddert Germany
Yoonjin Kwak relative to Laura Casorzo Italy Laura Casorzo's profile →
Citations per field
00.5×3.2×
Laura Casorzo · 1×
Citations per year

Countries citing papers authored by Yoonjin Kwak

Since Specialization
Citations

This map shows the geographic impact of Yoonjin Kwak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoonjin Kwak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoonjin Kwak more than expected).

Fields of papers citing papers by Yoonjin Kwak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoonjin Kwak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoonjin Kwak. The network helps show where Yoonjin Kwak may publish in the future.

Co-authorship network of co-authors of Yoonjin Kwak

This figure shows the co-authorship network connecting the top 25 collaborators of Yoonjin Kwak. A scholar is included among the top collaborators of Yoonjin Kwak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoonjin Kwak. Yoonjin Kwak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 4
5 8
6 1
7 8
8 8
9 2
10 5
11 9
12 0
13 1
14 0
15 19
16 1
17 51
18 11
19 47
20 24

About Yoonjin Kwak

Yoonjin Kwak is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 79 papers that have together received 1.4k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (23 papers), Cancer Immunotherapy and Biomarkers (17 papers) and Colorectal Cancer Treatments and Studies (15 papers). The work is most often cited by research in Oncology (949 citations), Pathology and Forensic Medicine (282 citations) and Cancer Research (231 citations). Yoonjin Kwak has collaborated with scholars based in South Korea, Ethiopia and United States. Frequent co-authors include Hye Seung Lee, Woo Ho Kim, Jiwon Koh, An Na Seo, Sung‐Bum Kang, Duck‐Woo Kim, Gheeyoung Choe, Soo Kyung Nam, Do Joong Park and Hyung‐Ho Kim. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026